Novel mechanisms of DNA topoisomerase II inhibition by pyranonaphthoquinone derivatives -: Eleutherin, α lapachone, and β lapachone

被引:92
|
作者
Krishnan, P [1 ]
Bastow, KF [1 ]
机构
[1] Univ N Carolina, Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA
关键词
naphthoquinones; topoisomerase II; catalytic inhibitors;
D O I
10.1016/S0006-2952(00)00437-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pyranonaphthoquinones have diverse biological activities against Gram positive bacteria, fungi and mycoplasms, and, recently, there has also been an increasing interest in their anti-cancer activity. This study includes three derivatives: eleutherin (compound 1), beta lapachone (compound 2), and its structural isomer, alpha lapachone (compound 3). The mechanism of topoisomerase II inhibition by the three derivatives was examined systematically with respect to the steps of the catalytic cycle of the enzyme. Etoposide, the prototypical enzyme poison, was used as a control and in combination with compounds 1-3 to localize their mechanism of action. The study revealed that eleutherin (1) and beta lapachone (2) inhibited topoisomerase II by inducing religation and dissociation of the enzyme from DNA in the presence of ATP. Whereas compound 2 was an "irreversible" inhibitor of topoisomerase II, compound 1 merely slowed the catalytic cycle of the enzyme. alpha Lapachone (3), on the other hand, inhibited initial non-covalent binding of topoisomerase II to DNA and, in addition, induced religation of DNA breaks (even in pre-established ternary complexes) before dissociating the enzyme from DNA. Compound 3 was an "irreversible" inhibitor of topoisomerase II. The diverse and unique mechanisms of topoisomerase II inhibition by pyranonaphthoquinone derivatives reveal novel ways to target the enzyme with potential for anti cancer drug design. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:1367 / 1379
页数:13
相关论文
共 50 条
  • [1] Novel mechanism of cellular DNA topoisomerase II inhibition by the pyranonaphthoquinone derivatives α-lapachone and β-lapachone
    Krishnan, P
    Bastow, KF
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 47 (03) : 187 - 198
  • [2] Concise Synthesis of (±)-Rhinacanthin A, Dehydro α-Lapachone, and β-Lapachone, and Pyranonaphthoquinone Derivatives
    Wang, Xue
    Chen, Ye
    Lee, Yong Rok
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2011, 32 (01) : 153 - 156
  • [3] New potential inhibitors of DNA topoisomerase. Part II: Design and synthesis of α-lapachone derivatives under microwave irradiation
    Wei, Ping
    Zhang, Xiaohong
    Tu, Shujiang
    Yan, Shu
    Ying, Hanjie
    Ouyang, Pingkai
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 828 - 830
  • [4] Reaction of β-lapachone and related naphthoquinones with 2-mercaptoethanol:: A biomimetic model of topoisomerase II poisoning by quinones
    Neder, K
    Marton, LJ
    Liu, LF
    Frydman, B
    CELLULAR AND MOLECULAR BIOLOGY, 1998, 44 (03) : 465 - 474
  • [5] Novel antitumor indenbindole derivatives targeting DNA and topoisomerase II
    Bal, C
    Baldeyrou, B
    Moz, F
    Lansiaux, A
    Colson, P
    Kraus-Berthier, L
    Lóence, S
    Pierré, A
    Boussard, MF
    Rousseau, A
    Wierzbicki, M
    Bailly, C
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (10) : 1911 - 1922
  • [6] Synthesis, cytotoxicity, DNA binding and topoisomerase II inhibition of cassiarin A derivatives
    Luesakul, Urarika
    Palaga, Tanapat
    Krusong, Kuakarun
    Ngarnrojanavanich, Nattaya
    Vilaivan, Tirayut
    Puthong, Songchan
    Muangsin, Nongnuj
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (13) : 2845 - 2850
  • [7] Discovery of novel triazolophthalazine derivatives as DNA intercalators and topoisomerase II inhibitors
    Sakr, Helmy
    Ayyad, Rezk R.
    El-Helby, Ali A.
    Khalifa, Mohamed M.
    Mahdy, Hazem A.
    ARCHIV DER PHARMAZIE, 2021, 354 (06)
  • [8] Design and Discovery of Novel Quinoxaline Derivatives as Dual DNA Intercalators and Topoisomerase II Inhibitors
    Eissa, Ibrahim H.
    El-Naggar, Abeer M.
    Abd El-Sattar, Nour E. A.
    Youssef, Ahmed S. A.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (02) : 195 - 209
  • [9] Topoisomerase II inhibition by the bioactivated benzene metabolite hydroquinone involves multiple mechanisms
    Mondrala, Scott
    Eastmond, David A.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2010, 184 (1-2) : 259 - 268
  • [10] Design and synthesis of dithiocarbamate linked β-carboline derivatives: DNA topoisomerase II inhibition with DNA binding and apoptosis inducing ability
    Kamal, Ahmed
    Sathish, Manda
    Nayak, V. Lakshma
    Srinivasulu, Vunnam
    Kavitha, Botla
    Tangella, Yellaiah
    Thummuri, Dinesh
    Bagul, Chandrakant
    Shankaraiah, Nagula
    Nagesh, Narayana
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (17) : 5511 - 5526